Skip to Main content Skip to Navigation
Master Thesis

Un néolymphocyte T pour une thérapie médicamenteuse de demain : « espoir ou réalité »

Abstract : Cancer treatment became a public health issue. The development of immunotherapy has increased of patient’s survival rate. Currently, adaptive cell therapy based on T cell is the most used one. T Cell is engineered a chimeric antigen receptor who binds to cancer cells causing the death of the cell. CART cell therapy is being studied in several clinical trials and the most encouraging results have been observed in haematological diseases.
Document type :
Master Thesis
Complete list of metadatas

Cited literature [202 references]  Display  Hide  Download

https://dumas.ccsd.cnrs.fr/dumas-01812056
Contributor : Santé Rennes 1 <>
Submitted on : Monday, June 11, 2018 - 10:57:18 AM
Last modification on : Thursday, July 9, 2020 - 12:30:44 PM

File

GARDANQuentin.pdf
Files produced by the author(s)

Identifiers

  • HAL Id : dumas-01812056, version 1

Collections

Citation

Quentin Gardan. Un néolymphocyte T pour une thérapie médicamenteuse de demain : « espoir ou réalité ». Sciences du Vivant [q-bio]. 2017. ⟨dumas-01812056⟩

Share

Metrics

Record views

20

Files downloads

136